Dr. Saver is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Stroke Center
710 Westwood Plaza, 1-240 RNRC
Los Angeles, CA 90095Phone+1 310-794-6379Fax+1 310-794-6379
Summary
- Dr. Jeffrey Saver is a neurologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica. He received his medical degree from Harvard Medical School and has been in practice 31 years. He specializes in stroke and vascular neurology and in behavioral and cognitive neurology. He has more than 775 publications and over 102,000 citings.
Education & Training
- Brown University/Rhode Island Hospital-LifespanFellowship, Vascular Neurology, 1991 - 1992
- Brown UniversityFellowship, Cerebrovascular disease, 1991 - 1992
- University of Iowa Hospitals and ClinicsResidency, Neurology, 1990 - 1991
- University of Iowa Hospitals and ClinicsFellowship, Cognitive Neuroscience, 1990 - 1991
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1987 - 1990
- Brigham and Women's HospitalInternship, Internal Medicine, 1986 - 1987
- Harvard Medical SchoolClass of 1986
Certifications & Licensure
- CA State Medical License 1994 - 2026
- IL State Medical License 1992 - 1996
- IA State Medical License 1990 - 1993
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
Clinical Trials
- Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial Start of enrollment: 2005 Jan 01
- A Randomized Trial of Unruptured Brain AVMs Start of enrollment: 2006 Oct 01
- Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial Start of enrollment: 2003 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Mobile stroke units services in Germany: A cost-effectiveness modeling perspective on catchment zones, operating modes, and staffing.Johann S Rink, Kristina Szabo, Carolin Hoyer, Jeffrey L Saver, May Nour
European Journal of Neurology. 2025-01-01 - A Prospective Multicenter Analysis of Mobile Stroke Unit Cost-Effectiveness.Suja S Rajan, Jose-Miguel Yamal, Mengxi Wang, Jeffrey L Saver, Asha P Jacob
Annals of Neurology. 2024-12-03 - 1 citationsIntravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.Kevin N Sheth, Gregory W Albers, Jeffrey L Saver, Bruce C V Campbell, Bradley J Molyneaux
The Lancet. Neurology. 2024-12-01
Journal Articles
- Stroke Thrombolysis with Tenecteplase to Reduce Emergency Department Spread of Coronavirus Disease 2019 and Shortages of AlteplaseSteven J Warach, Jeffrey L Saver, JAMA Neurology
- Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients with Acute Ischemic StrokeShumei Man, Jeffrey L Saver, Eric E Smith, Deepak L Bhatt, Lee H Schwamm, Gregg C Fonarow, JAMA
- Striving for Ideal Cardiovascular and Brain HealthMary Cushman, Jeffrey L Saver, JAMA
- Join now to see all
Lectures
- Transcranial Doppler CourseDavid Geffen School of Medicine at UCLA, Los Angeles, California - 7/24/2013
- Transcranial Doppler CourseUCLA Health System, Los Angeles, California - 2/13/2013
- Transcranial Doppler CourseUCLA Health System, Los Angeles, California - 11/14/2012
- Join now to see all
Authored Content
- Stroke Thrombolysis with Tenecteplase to Reduce Emergency Department Spread of Coronavirus Disease 2019 and Shortages of AlteplaseJuly 2020
- Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients with Acute Ischemic StrokeJune 2020
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctNovember 2017
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctNovember 2017
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctNovember 2017
- Join now to see all
Press Mentions
- Preventing Fever in Patients with Acute Vascular Brain InjurySeptember 25th, 2024
- Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60May 17th, 2024
- Results from BRAIN.q's EMAGINE Study on the Use of AI-Powered Electromagnetic Field Therapy Offer Hope for Meaningful Recovery Following StrokeMay 16th, 2024
- Join now to see all
Grant Support
- Field Administration Of Stroke Therapy-Magnesium Trial (Fast-Mag)National Institute Of Neurological Disorders And Stroke2008–2012
- UCLA Spotrias Center Application Renewal-Program ProjectNational Institute Of Neurological Disorders And Stroke2008–2011
- Telestroke In The FieldNational Institute Of Neurological Disorders And Stroke2008–2011
- Field Administration Of Stroke Therapy-Magnesium Trial (Fast-MagNational Institute Of Neurological Disorders And Stroke2008–2011
- Carrer DevelopmentNational Institute Of Neurological Disorders And Stroke2008–2011
- Administrative CoreNational Institute Of Neurological Disorders And Stroke2008–2011
- UCLA Spotrias CenterNational Institute Of Neurological Disorders And Stroke2009
- UCLA Spotrias Center ApplicationNational Institute Of Neurological Disorders And Stroke2003–2007
- Prehospital Stroke StudiesNational Institute Of Neurological Disorders And Stroke2003–2007
- Field Administration Of Stroke Therapy - Magnesium TrialNational Institute Of Neurological Disorders And Stroke2003–2007
- Core--Career DevelopmentNational Institute Of Neurological Disorders And Stroke2003–2007
- Paramedic Field Initiation Of Magnesium NeuroprotectiveNational Institute Of Neurological Disorders And Stroke1999–2003
- Vitamin Intervention For Stroke Prevention (VISP)National Center For Research Resources1999–2001
- Vitamine Intervention For Stroke Prevention (VISP)National Center For Research Resources1998
- Randomized Trial Of ORG 10172 In Actue Or Progressing Ischemic StrokeNational Center For Research Resources1996–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: